Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren Effect on Kidney Metabolism in Transplant Patients
NCT01437943Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aliskiren in kidney failure (ESRD), sponsored by Brigham and Women's Hospital. Started Apr 2010; status: terminated.
02
Drugs
aliskiren
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT01437943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437943.